metastatic microsatellite instability high
PURPOSEKEYNOTE-164(NCT02460198)evaluatedtheantitumoractivityofpembrolizumabinpreviouslytreated,metastatic,microsatelliteinstability–high/mismatch,由HJLenz著作·2022·被引用313次—First-LineNivolumabPlusLow-DoseIpilimumabforMicrosatelliteInstability-...
Phase II Open
- 衛星不穩定性
- metastatic microsatellite instability high
- microsatellite instability大腸癌
- microsatellite instability test
- microsatellite instability中文
- microsatellite instability test
- microsatellite instability-high中文
- microsatellite instability中文
- microsatellite instability中文
- microsatellite instability大腸癌
- microsatellite instability immunotherapy
- microsatellite instability immunotherapy
- Microsatellite instability-high
- msi-h
- microsatellite instability大腸癌
- microsatellite instability 中文
- Microsatellite instability-high
- metastatic microsatellite instability high
- microsatellite instability colon cancer
- msi-h
- microsatellite instability-high cancer中文
- metastatic microsatellite instability high
- microsatellite instability analysis
- microsatellite instability immunotherapy
- msi test
PURPOSEKEYNOTE-164(NCT02460198)evaluatedtheantitumoractivityofpembrolizumabinpreviouslytreated,metastatic,microsatelliteinstability–high/mismatch
** 本站引用參考文章部分資訊,基於少量部分引用原則,為了避免造成過多外部連結,保留參考來源資訊而不直接連結,也請見諒 **